HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luca Proietti-De-Santis Selected Research

methyltrioxorhenium VII

1/2019Oxidative nucleophilic substitution selectively produces cambinol derivatives with antiproliferative activity on bladder cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luca Proietti-De-Santis Research Topics

Disease

11Cockayne Syndrome (Syndrome, Cockayne)
03/2022 - 05/2006
7Neoplasms (Cancer)
09/2021 - 03/2009
1Triple Negative Breast Neoplasms
03/2022
1Breast Neoplasms (Breast Cancer)
03/2022
1Neuroblastoma
09/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2019
1Inborn Genetic Diseases (Disease, Hereditary)
04/2011
1Hypoxia (Hypoxemia)
03/2009

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
03/2022 - 05/2006
3Biological ProductsIBA
09/2021 - 03/2009
1Pharmaceutical PreparationsIBA
03/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2020
1UbiquitinIBA
12/2020
1cambinolIBA
01/2019
1methyltrioxorhenium VIIIBA
01/2019
1ChromatinIBA
01/2015
1RNA (Ribonucleic Acid)IBA
01/2015
1Staphylococcal Protein A (Protein A)IBA
04/2013
1PyrimidinesIBA
04/2011
1PurinesIBA
04/2011
1DNA (Deoxyribonucleic Acid)IBA
04/2011

Therapy/Procedure

3Therapeutics
09/2021 - 01/2018
2Drug Therapy (Chemotherapy)
03/2022 - 01/2021